Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Shattuck Labs, Inc. (STTK)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/31/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 40,258 options to buy
@ $2.72, valued at
$109.5k
|
|
05/31/2023 |
4
| Lee Michael Stewart (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 40,258 options to buy
@ $2.72, valued at
$109.5k
|
|
05/31/2023 |
4
| Boudreau Helen M (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 40,258 options to buy
@ $2.72, valued at
$109.5k
|
|
05/31/2023 |
4
| Golumbeski George (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 40,258 options to buy
@ $2.72, valued at
$109.5k
|
|
05/31/2023 |
4
| Gibson Neil W (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 40,258 options to buy
@ $2.72, valued at
$109.5k
|
|
05/31/2023 |
4
| Brownstein Carrie (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 40,258 options to buy
@ $2.72, valued at
$109.5k
|
|
05/31/2023 |
4
| Brous Tyler (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 40,258 options to buy
@ $2.72, valued at
$109.5k
|
|
01/27/2023 |
4
| Neill Andrew R (CFO) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 34,925 shares
@ $0 Granted 69,850 options to buy
@ $3.57, valued at
$249.4k
|
|
01/27/2023 |
4
| Thomson Erin Ator (General Counsel) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 24,125 shares
@ $0 Granted 48,250 options to buy
@ $3.57, valued at
$172.3k
|
|
01/27/2023 |
4
| Shukla Abhinav A. (Chief Technical Officer) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 26,100 shares
@ $0 Granted 52,200 options to buy
@ $3.57, valued at
$186.4k
|
|
01/27/2023 |
4
| Pandite Arundathy N. (Chief Medical Officer) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 37,875 shares
@ $0 Granted 69,750 options to buy
@ $3.57, valued at
$249k
|
|
01/27/2023 |
4
| DeYoung Casi (Chief Business Officer) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 27,100 shares
@ $0 Granted 54,200 options to buy
@ $3.57, valued at
$193.5k
|
|
01/27/2023 |
4
| Schreiber Taylor (CEO) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 165,050 options to buy
@ $3.57, valued at
$589.2k
|
|
01/12/2023 |
4
| DeYoung Casi (Chief Business Officer) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Paid exercise price by delivering 1,583 shares
@ $3.03, valued at
$4.8k
|
|
01/12/2023 |
4
| Pandite Arundathy N. (Chief Medical Officer) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Paid exercise price by delivering 2,987 shares
@ $3.03, valued at
$9.1k
|
|
01/12/2023 |
4
| Shukla Abhinav A. (Chief Technical Officer) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Paid exercise price by delivering 1,933 shares
@ $3.03, valued at
$5.9k
|
|
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Brous Tyler (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 40,258 options to buy
@ $4.32, valued at
$173.9k
|
|
06/10/2022 |
4
| Brownstein Carrie (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 40,258 options to buy
@ $4.32, valued at
$173.9k
|
|
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2022 |
4
| Golumbeski George (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Bought 28,330 shares
@ $3.63, valued at
$102.8k
|
|
04/26/2022 |
4
| Golumbeski George (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Bought 26,049 shares
@ $3.69, valued at
$96.1k
Bought 234 shares
@ $3.67, valued at
$858.8 |
|
01/31/2022 |
4
| Schreiber Taylor (CEO) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Exercised 3,926 options to buy
@ $4.67, valued at
$18.3k
|
|
01/19/2022 |
4
| Brous Tyler (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Bought 2,500 shares
@ $7.16, valued at
$17.9k
Bought 2,500 shares
@ $7.01, valued at
$17.5k
Bought 3,000 shares
@ $6.87, valued at
$20.6k
|
|
01/12/2022 |
4
| DeYoung Casi (Chief Business Officer) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 21,363 shares
@ $0 Granted 42,725 options to buy
@ $7.43, valued at
$317.4k
|
|
01/12/2022 |
4
| Pandite Arundathy N. (Chief Medical Officer) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 34,738 shares
@ $0 Granted 69,475 options to buy
@ $7.43, valued at
$516.2k
|
|
01/12/2022 |
4
| Neill Andrew R (CFO) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 33,325 shares
@ $0 Granted 66,650 options to buy
@ $7.43, valued at
$495.2k
|
|
01/12/2022 |
4
| Thomson Erin Ator (General Counsel) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 22,825 shares
@ $0 Granted 45,650 options to buy
@ $7.43, valued at
$339.2k
Exercised 10,000 options to buy
@ $2.95, valued at
$29.5k
|
|
01/12/2022 |
4
| Schreiber Taylor (CEO) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 178,150 options to buy
@ $7.43, valued at
$1.3M
|
|
11/17/2021 |
4
| Brownstein Carrie (Director) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Granted 10,467 options to buy
@ $19.27, valued at
$201.7k
|
|
11/12/2021 |
4
| Neill Andrew R (CFO) has filed a Form 4 on Shattuck Labs, Inc.
Txns:
| Exercised 20,000 options to buy
@ $2.95, valued at
$59k
|
|
|
|
|